These compounds may interact with:
5-hydroxytryptamine receptor 3A
Potentially involved in: carcinoma; irritable bowel syndrome; constipation; diarrhea; motion sickness; pain agnosia; schizophrenia; migraine; cancer; fibromyalgia; dyspepsia; ischemic colitis; alcohol dependence; anxiety disorder; substance abuse; amnestic disorder; gastroparesis; major depressive disorder; alcohol use disorder; alcoholic intoxication, chronic
Disease data sourced from Pharos.